Filter Results:
(87)
Show Results For
- All HBS Web (345)
- Faculty Publications (138)
Show Results For
- All HBS Web (345)
- Faculty Publications (138)
Sort by
- 04 Nov 2016
- News
The Competitiveness of Lost Causes
regulations, in part by helping producers secure public guarantees for financing a $17 million water treatment plant. “That was a success story that saved and created jobs and became the basis of an HBS case,” notes Duch. “Today everyone... View Details
Keywords: Deborah Blagg
- 01 Mar 2009
- News
Model Patient
care, plus some drug coverage — was rejected. It smacked of a “two-tiered” system, he says, and was unacceptable for political reasons. Costs have thus been significantly higher than expected because the standard plan — with a relatively... View Details
- 24 Apr 2014
- News
Finding a cure so that others may benefit
call. The foundation wanted to invest in for-profit bioscience companies to spur scientists to find a cure for the disease. O’Donnell is credited with almost singlehandedly raising $250 million in support of this venture philanthropy, which led to the development of... View Details
- 01 Dec 2004
- News
Finding a Balance
Do the rules of business change when a company’s product holds the power of life or death over its customers? That’s a question students must consider when discussing “Cipla,” a case about a $325 million Indian pharmaceutical company that manufactures and sells... View Details
- 05 May 2020
- News
“Walking a Tightrope”
is going to be transmitted yet again to the next generation. A year and a half, two years ago now, we ran into Drew. He was in a drug treatment program called Provoking Hope based in McMinnville, Oregon.... View Details
- 01 Mar 2013
- News
Opening the Door
neighborhood-based health plan for the city of Charlestown, and I became involved in building a system of benchmarks for the various services that were being offered—everything from dental care to drug and alcohol abuse counseling. I... View Details
- 24 Sep 2020
- News
The Race for a Vaccine
a computer model of a potential mRNA-based vaccine. Twenty-five days after that, it produced the first dose of a treatment it hoped would protect against a disease that did not yet have a name. On February 24, after 17 days of analysis... View Details
- 25 Jun 2020
- News
Covering All Corners
is coordinating with Gilead Sciences, maker of Remdesivir, to distribute and manufacture the antiviral drug treatment for use in 127 countries, including Egypt. It was recently approved for emergency use by... View Details
- 01 Jun 2009
- News
Cynthia Carroll
in enterprise development through our incubator units in South Africa and Chile, which support over 220 freestanding businesses providing jobs to some 13,500 people. In South Africa, I’m also very proud that we have the largest workplace HIV testing and View Details
- 01 Dec 2018
- News
Case Study: Your Data, Your Health
the cost of paying for health insurance subscribers, which will bring higher returns for the insurance company. We have seen this in the drug Angiomax by the Medicines Company. —Suleiman Yakasai (PLDA 22, 2016) Got a case? To take part in... View Details
Keywords: Jen McFarland Flint
- 01 Dec 2001
- News
Reaching Out
Ph.D. in pathology and molecular biology at Boston University's School of Medicine. Intrigued by his experience with pharmaceutical companies and the role of business in drug delivery, he enrolled at HBS one month after finishing his... View Details
- 04 Sep 2019
- News
Advancing Diagnostics that Can Save Lives
who spent six years commercializing drugs and diagnostics in East and West Africa before earning her MBA. “There are frequently delays in diagnosis, where the turnaround time for a biopsy could be several weeks or months.” That lag time,... View Details
Keywords: Susan Young
- 01 Sep 2018
- News
September 2018 Alumni and Faculty Books
Forsythe stories feature a talented African American man, wrongfully imprisoned, who becomes a successful drug lord. The Carmichael stories feature two generations of Swedish immigrants in upstate New York, facing—or avoiding—the... View Details
- 01 Dec 2013
- News
Curing Health Care
Massachusetts Governor Deval Patrick joked in his speech.) Related Links A Blueprint for Patient-Driven Drug Development Gene Williams (MBA 1987) Blavatnik Gift Accelerates Biomedical Advances Oscar Winners Even worse is what... View Details
- 01 Jun 2007
- News
Mission Possible
really works.” Henry McCance (MBA ’66) Cure Alzheimer’s Fund www.curealzfund.org When his wife was diagnosed seven years ago with the early stages of Alzheimer’s disease, Henry McCance found himself searching for the best treatments in... View Details
- 01 Jun 2020
- News
Prognosis
fact that we knew the genetic sequence of it within a few weeks, the fact that there are vaccine candidates being tried in humans, that perhaps we’ll see a drug that is effective against it—the power of biomedical research in the year... View Details
- 01 Dec 2008
- News
Business at the Summit
Gates said, does many things well, but the inspiration for the Bill & Melinda Gates Foundation came in part from a market failure in health-care delivery. Individuals who live in areas where tuberculosis, AIDS, and malaria are still common are often too poor to afford... View Details
- 15 Dec 2015
- News
The Year in Ideas 2015
to something big. After a second field study, Solomon and Hillerstrom launched NeuroPhage. In tests on mice, the drug they developed improved both memory and cognitive abilities. “We believe it can identify harmful aggregates in the... View Details
- 19 Mar 2015
- News
Walter Salmon Remembered
received a similar treatment from our section. That show of affection indicated that many of my section mates felt as I did about the impact he had on our thinking about the subject of marketing. You will be missed, Professor Salmon.... View Details